WESTBOROUGH, Mass., Nov. 4 /PRNewswire/ -- IBC's 2nd Annual International conference on Antibody Therapeutics, to be held November 30 - December 3, 2004 at the Sheraton San Diego Hotel & Marina in CA, will feature two industry leaders to address its keynotes. Ronald Levy, M.D., Professor and Chief in the Division of Oncology for Stanford School of Medicine will address "Antibodies are Drugs - Now We Need to Understand Them and Improve Them." The following day Jennie P. Mather, Ph.D., President and CEO of Raven Biotechnologies, Inc. will address "Antibody therapeutics: From Failure to Market Leader."
This event was created for the research community, business experts and clinicians to discuss the issues pertaining to not only the technological development but also the evolving nature of the antibody business, market trend, finance outlook, and challenges in the development of next generation of antibody therapeutic products. Featuring first-hand information on how successful antibody companies are approaching their clinical development programs and structuring business deals, Antibody Therapeutics will be held in conjunction with IBC's antibody flagship event, Antibody Engineering.
The Antibody Therapeutics conference will cover:
-- Capital Market, Clinical Trials and Regulatory Environment
-- Business Development, Technology Transfer and Partnering Strategies
-- Technology Highlights
-- Clinical Study Status and Pre-Clinical and Clinical Development
of Recombinant Antibodies
-- Production
In addition a Panel Discussion is offered covering Complex Intellectual Property Issues of the Antibody Sector.
The Antibody Therapeutics attendees will have access to selected sessions of the co-located Antibody Engineering conference and full access to the shared exhibit and poster hall allowing attendees to share networking functions with over 600 attendees, 30 exhibits, and 50 posters while having programming specifically designed for their needs. The Antibody Engineering event is the largest of its kind, bringing in over 50 of the world's leading experts to present new information.
In addition Attendees will be able to take advantage of Attendee Connect, a software program that allows attendees to schedule meetings pre-event with fellow peers to maximize their time at the event.
ATTENTION CALENDAR EDITORS! For more information on attending Antibody Therapeutics at the Sheraton San Diego Hotel & Marina, San Diego, CA, visit http://www.lifesciencesinfo.com/3062; call 508-616-5550 or e-mail kpatterson@ibcusa.com.
IBC Life SciencesCONTACT: Kerry Patterson of IBC, +1-508-616-5550, kpatterson@ibcusa.com
Web site: http://www.lifesciencesinfo.com/